The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018
Obesity in pediatric asthma: prevalence and impact on severity Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017
Asthma in adults: association of asthma symptoms and age at asthma diagnosis Source: Virtual Congress 2020 – Risk factors for chronic lung diseases Year: 2020
Predictors for asthma onset from cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002
TB infection decreases asthma prevalence and severity of symptoms Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013
Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005
Noneosinophilic asthma: persistence over time and effect of treatment Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Severe asthma: classification and treatment Source: Virtual Congress 2021 – Clinical year in review Year: 2021
Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma? Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017 Year: 2017
Severe asthma: approach to diagnosis and treatment Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008
‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study Source: Annual Congress 2011 - Asthma management and response Year: 2011
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013
Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis Source: Eur Respir J 2016; 48: 1063-1073 Year: 2016
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016